Lassa fever outbreak claims 142 lives across 18 Nigerian states. NCDC reports 747 confirmed cases, with Ondo, Bauchi, and Edo states hardest hit. Urgent action needed.

Renowned virologist, Dr Simeon Agwale, has hinted that Lassa fever vaccine produced by a Nigerian has scaled through preclinical trials involving mice and non-human primates.

Lassa fever has persisted as a public health burden in Nigeria, claiming lives, especially in rural and under-resourced communities.

Lassa fever continues to pose a significant public health threat in Nigeria, particularly during the dry season. According to the Nigeria Centre for Disease Control and Prevention (NCDC), the ...

Lassa fever killed 118 people in Nigeria in the first three months of this year, the West African country's Centre for Disease Control and Prevention (NCDC) said.

The NIH announced the beginning of a phase 1 first-in-human trial of a vaccine for Lassa fever, a potentially fatal viral hemorrhagic disease for which there is no approved vaccine or treatment.

An NIH-sponsored clinical trial of a candidate vaccine to prevent Lassa fever has begun enrolling participants.

The UK Health Security Agency is investigating possible Lassa fever cases after a traveler was diagnosed with the virus. The disease, which shares similarities with Ebola, requires immediate ...

What are the symptoms? Lassa fever causes acute infections which can range from very mild symptoms through to a severe viral haemorrhagic fever.

What is Lassa fever? Lassa fever is an acute viral haemorrhagic illness, belonging to the virus family Arenaviridae, that lasts between two and 21 days, according to the World Health Organisation ...

Nigeria is set to host its inaugural regional meeting on Lassa fever vaccine development on January 15, 2025, showcasing its leadership in tackling one of West Africa’s most pressing public ...

The News spoke with three Yale experts following the death of an Iowa resident from Lassa fever.